Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - ANAVEX LIFE SCIENCES CORP. | form8k.htm |
ANAVEX LIFE SCIENCES CORP.
INTERIM CONDENSED
CONSOLIDATED BALANCE SHEETS
September 15, 2015 and September 30,
2014
(Unaudited)
ASSETS
| September 15, | September 30, | |||||
| 2015 | 2014 | |||||
| Current | ||||||
| Cash | $ | 13,101,846 | $ | 7,262,138 | ||
| Prepaid expenses | 79,321 | 89,117 | ||||
| Total current assets | 13,181,167 | 7,351,255 | ||||
| Equipment | 1,501 | 2,247 | ||||
| Total assets | $ | 13,182,668 | $ | 7,353,502 |
LIABILITIES
| Current | ||||||
| Accounts payable and accrued liabilities | $ | 1,016,369 | $ | 1,249,084 | ||
| Promissory notes payable | 92,516 | 192,065 | ||||
| Total current liabilities | 1,108,885 | 1,441,149 | ||||
| Non-interest bearing liabilities | 436 | 5,719,727 | ||||
| Total liabilities | 1,109,321 | 7,160,876 |
STOCKHOLDERS' EQUITY
| Capital stock | ||||||
| Authorized: | ||||||
| 400,000,000 common shares, par value $0.001 per share | ||||||
| Issued and outstanding: | ||||||
| 124,503,297 common shares (September 30, 2014 - 47,200,237) | 124,503 | 47,201 | ||||
| Additional paid-in capital | 72,949,380 | 52,078,750 | ||||
| Common stock to be issued | 777,415 | 640,000 | ||||
| Accumulated deficit | (61,777,951 | ) | (52,573,325 | ) | ||
| Total stockholders' equity | 12,073,347 | 192,626 | ||||
| Total liabilities and stockholders' equity | $ | 13,182,668 | $ | 7,353,502 |